HEALTHALLAFRICA
Congo-Kinshasa: Unicef and Gavi Launch Call to Manufacturers in Support of Accelerated Access to Bundibugyo Ebolavirus Vaccines
UNICEF and Gavi launched a Request for Expression of Interest to gather information from vaccine developers and manufacturers about plans to create a Bundibugyo Ebolavirus vaccine. Gavi has committed $40 million to support accelerated access to the vaccine.
Mentioned
Related Signal
Adjacent reporting
- Moderna gets $50M investment for Ebola vaccine candidate
- CEPI invests $1.9m to accelerate Ebola Vaccine development
- Moderna gets $50 million to develop mRNA Ebola vaccine against Bundibugyo
- Healthy Returns: Eli Lilly makes a new push into vaccines – here’s what to know
- STAT+: Global coalition to fast-track three vaccines targeting Ebola outbreak with $62 million in funding
- Inside the race to develop a new Ebola vaccine